Last reviewed: June 21, 2026
Last updated: June 21, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, the active ingredient in Wegovy, follows a carefully structured dose escalation protocol that starts low and increases every four weeks. The maximum therapeutic dose for weight loss is 2.4 mg injected once weekly, though many patients experience significant results at lower maintenance doses. Understanding how dosing works helps you make informed decisions about your treatment plan.
Understanding Semaglutide Dose Escalation Schedules
Semaglutide dosing begins at 0.25 mg weekly and increases by 0.25 mg increments every four weeks, following a deliberate titration pattern designed to minimize side effects and allow your body to adapt. This gradual approach helps reduce nausea, vomiting, and gastrointestinal discomfort that can occur when doses jump too quickly. Most patients move through four dose steps before reaching the 2.4 mg maintenance level, though individual timelines may vary based on tolerance.
The standard 16-week escalation path looks like this: weeks 1-4 at 0.25 mg, weeks 5-8 at 0.5 mg, weeks 9-12 at 1.0 mg, weeks 13-16 at 1.5 mg, and then continuation at higher doses if tolerated. Some patients stay at intermediate doses like 1.5 mg or 2.0 mg and see excellent weight loss outcomes without advancing further. Your healthcare provider determines the optimal stopping point based on your response, tolerance, and weight loss goals.
Is 2.4 mg the Maximum Effective Dose for Weight Loss
Clinical trials show that 2.4 mg weekly represents the highest approved dose for chronic weight management, but research indicates that meaningful weight loss often occurs at lower doses like 1.5 mg or 2.0 mg. The STEP trials demonstrated that participants on 2.4 mg achieved approximately 18% body weight reduction over 68 weeks, while those on 1.5 mg achieved around 15% reduction. This suggests a dose-response relationship exists, but the difference narrows at higher doses, meaning you don't necessarily need the maximum to succeed.
Individual factors like genetic predisposition, metabolism, and GLP-1 receptor sensitivity influence how effectively a particular dose works for your body. Two patients on identical doses may experience different weight loss trajectories, which is why personalized assessment matters. Staying at a lower effective dose that you tolerate well often produces better long-term outcomes than struggling with side effects at higher doses.
Factors That Influence Your Optimal Semaglutide Dose
Your ideal semaglutide dose depends on multiple factors including baseline weight, metabolic health, gastrointestinal sensitivity, and how your body's GLP-1 receptors respond to the medication. Genetic variations in genes like GLP1R and FTO influence how efficiently semaglutide works in your system, meaning some people achieve results at 1.5 mg while others benefit from advancing to 2.4 mg. PlexusDx's Precision Peptide Genetic Test maps 14 metabolic pathways across 49 peptides to identify your unique response profile, helping guide dose decisions.
Kidney function, liver health, and concurrent medications also affect how your body processes semaglutide and tolerates escalating doses. Patients with diabetes may require different dosing strategies than those using semaglutide purely for weight management. A comprehensive health evaluation before starting treatment and ongoing monitoring during dose escalation ensures you reach your effective dose safely without unnecessary side effects.
Affordable Semaglutide at Every Dose Level with PlexusDx
PlexusDx offers compounded semaglutide injections from licensed 503A compounding pharmacies starting at $149 per month, with transparent pricing that remains flat regardless of whether you're at 0.25 mg or 2.4 mg—because your dose may need to go up, but your price won't. This pricing structure removes the financial pressure to advance to higher doses if lower doses work effectively for you, letting clinical response guide decisions rather than cost concerns. All 50 states are served with no insurance requirement, membership fees, or hidden charges.
HSA and FSA accounts cover PlexusDx medications, making treatment accessible to more patients regardless of insurance status. After your first month of treatment, you can add the Precision Peptide Genetic Test for just $99 to identify how your unique genetic makeup influences peptide sensitivity and GLP-1 pathway function. This combination of affordable dosing and personalized genetic insights helps you find your optimal treatment plan without breaking the bank.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I stop at a lower dose if it's working for my weight loss?
Yes, absolutely. Your target dose is the lowest amount that produces meaningful weight loss you can sustain long-term while managing side effects well. Many patients achieve excellent results at 1.5 mg or 2.0 mg and choose not to advance further, which reduces side effect risk and improves treatment satisfaction. Your provider can help determine whether your current dose is optimized for your goals.
What percentage of weight loss happens at 2.4 mg versus lower doses?
The STEP clinical trials showed 2.4 mg produces approximately 18% body weight reduction while 1.5 mg produces about 15% reduction over the same timeframe. The relative difference narrows at higher doses, meaning you gain progressively less additional benefit with each dose increase. This dose-response plateau means that lower doses often represent the sweet spot for many patients between effectiveness and tolerability.
How much does semaglutide cost at different dose levels with PlexusDx?
PlexusDx compounded semaglutide injections cost $149 per month flat, regardless of whether you're taking 0.25 mg or 2.4 mg. Your price doesn't change as your dose increases, removing financial barriers to finding your optimal therapeutic dose. Treatment is available in all 50 states with no insurance needed, and HSA/FSA accounts are eligible.
What side effects might I experience when increasing from 1.5 mg to 2.4 mg?
Common side effects with dose escalation include nausea, vomiting, constipation, and reduced appetite, typically occurring most intensely for 1-2 weeks after each dose increase before tolerating improves. More severe but rare effects include pancreatitis and gallbladder complications, which is why medical supervision during titration matters. If side effects become intolerable at a higher dose, discussing a step-back to a lower effective dose with your provider is appropriate and often produces better long-term adherence.
Can genetic testing help predict whether I need higher semaglutide doses?
PlexusDx's Precision Peptide Genetic Test identifies variations in genes like GLP1R and FTO that influence how effectively semaglutide works in your body, helping predict whether you're likely to need higher doses for results. The test maps 14 metabolic pathways across 49 peptides to reveal 150+ personalized insights about your peptide sensitivity. This genetic data, combined with your clinical response over the first few weeks, helps your provider anticipate your optimal dose range before committing to expensive titration.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Does Wegovy Have to Be Room Temp Before Injection?
Is 0.5 Ozempic Enough for Weight Loss? Exploring the Efficacy of This Dosage